Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

kbiosystems Ltd UK Custom Project Division See Sharp Increase in Business

Published: Thursday, January 02, 2014
Last Updated: Thursday, January 02, 2014
Bookmark and Share
Company has seen an increase in the number of custom automation projects globally with the added benefit of entering in to new market sectors.

John Woodford, Director of kbiosystems Ltd, who is spearheading the changes, commented “Over the last few years our business has grown and the markets we now serve have. We continue to provide standard products for the Life Sciences industry with some exciting new products due for launch in 2014, our custom project division are working in differing industries to those we did in the past. These industries include Biofuels, Diagnostics and the Optical Lens production, third party OEM and full production automation both large and small”.

Although the projects worked on have all been under non-disclosure agreements, the diversity of requirements highlights the expertise kbiosystems Ltd have in house to adapt to the ever changing needs of the clients.

John Woodford, who heads up this division and part owner of kbiosystems Ltd says “Our key strength is the ability to take a concept from our clients and provide them with a detailed plan of the end product designed from our own design department. With a manufacturing workshop, having recently had a £250,000 investment, we are able to provide our clients with a solution that exceeds their expectations”. He adds “We pride ourselves on designing and engineering solutions that are robust and stand the test of time. Many products are still working from our early days. The after sales care is second to none and believe in building long lasting relationships with customers that culminates in repeat and referred business”.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos